Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism
出版年份 2023 全文链接
标题
Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism
作者
关键词
-
出版物
JOURNAL OF HEPATOLOGY
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-10-31
DOI
10.1016/j.jhep.2023.10.024
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The AGH score is a predictor of disease-free survival and targeted therapy efficacy after liver transplantation in patients with hepatocellular carcinoma
- (2022) Jian-Hua Li et al. Hepatobiliary & Pancreatic Diseases International
- GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors
- (2022) Yunzheng Li et al. CANCER RESEARCH
- Strategies for improving the efficacy of immunotherapy in hepatocellular carcinoma
- (2022) Ying Zhu et al. Hepatobiliary & Pancreatic Diseases International
- Roles of lncRNA LVBU in regulating urea cycle/polyamine synthesis axis to promote colorectal carcinoma progression
- (2022) Xiangqi Meng et al. ONCOGENE
- Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer
- (2022) Hannah N. Bell et al. Cell Metabolism
- Clinical heterogeneity of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome in thirteen palestinian patients and report of a novel variant in the SLC25A15 gene
- (2022) Imad Dweikat et al. Frontiers in Genetics
- Hypoxia associated multi-omics molecular landscape of tumor tissue in patients with hepatocellular carcinoma
- (2021) Qiangnu Zhang et al. Aging-US
- A novel hypoxia gene signature indicates prognosis and immune microenvironments characters in patients with hepatocellular carcinoma
- (2021) Qiangnu Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- 4‐phenylbutyric acid promotes hepatocellular carcinoma via initiating cancer stem cells through activation of PPAR‐α
- (2021) Shu‐Zhen Chen et al. Clinical and Translational Medicine
- Discovery of a CPS1‐deficient HCC subtype with therapeutic potential via integrative genomic and experimental analysis
- (2021) Tong Wu et al. HEPATOLOGY
- Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
- (2021) Danyu Du et al. Acta Pharmaceutica Sinica B
- Immunosuppression Induced by Glutamine Deprivation Occurs via Activating PD-L1 Transcription in Bladder Cancer
- (2021) Liping Wang et al. Frontiers in Molecular Biosciences
- PGC1α suppresses metastasis of HCC by inhibiting Warburg effect via PPARγ‐dependent WNT/β‐catenin/PDK1 axis
- (2020) Qiaozhu Zuo et al. HEPATOLOGY
- PLAGL2‐EGFR‐HIF‐1/2α signaling loop promotes HCC progression and Erlotinib insensitivity
- (2020) Weiwei Hu et al. HEPATOLOGY
- A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer
- (2020) Haojie Jin et al. eLife
- p53 regulation of ammonia metabolism through urea cycle controls polyamine biosynthesis
- (2019) Le Li et al. NATURE
- Significant Down-Regulation of Urea Cycle Generates Clinically Relevant Proteomic Signature in Hepatocellular Carcinoma Patients with Macrovascular Invasion
- (2019) Yin Cao et al. JOURNAL OF PROTEOME RESEARCH
- Aberrant hypermethylation of OGDHL gene promoter in sporadic colorectal cancer
- (2019) Mohammad Khalaj-kondori et al. CURRENT PROBLEMS IN CANCER
- Circular RNA MAT2B Promotes Glycolysis and Malignancy of Hepatocellular Carcinoma Through the miR‐338‐3p/PKM2 Axis Under Hypoxic Stress
- (2019) Qing Li et al. HEPATOLOGY
- A Novel oxoglutarate dehydrogenase-like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis
- (2019) Yao Liu et al. CLINICAL CANCER RESEARCH
- Inhibition of mTOR complex 1/p70 S6 kinase signaling elevates PD-L1 levels in human cancer cells through enhancing protein stabilization accompanied with enhanced β-TrCP degradation
- (2019) Liang Deng et al. ONCOGENE
- Circular RNA circFOXO3 promotes prostate cancer progression through sponging miR‐29a‐3p
- (2019) Zhe Kong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Glutamine Deprivation Induces PD-L1 Expression via Activation of EGFR/ERK/c-Jun Signaling in Renal Cancer
- (2019) Guofeng Ma et al. MOLECULAR CANCER RESEARCH
- A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells
- (2019) Hee Chan Yoo et al. Cell Metabolism
- Discovery of rare coding variants in OGDHL and BRCA2 in relation to breast cancer risk in Chinese women
- (2019) Xingyi Guo et al. INTERNATIONAL JOURNAL OF CANCER
- OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism
- (2019) W.Q. Dai et al. JOURNAL OF HEPATOLOGY
- Overexpression of SLC25A15 is involved in the proliferation of cutaneous melanoma and leads to poor prognosis
- (2018) Shu-meng Ji M S-MEDECINE SCIENCES
- Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway
- (2018) Binghua Li et al. EBioMedicine
- Hypoxia reduces HNF4α/MODY1 protein expression in pancreatic β-cells by activating AMP-activated protein kinase
- (2017) Yoshifumi Sato et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC
- (2017) Mi-Jin Kim et al. MOLECULAR CANCER RESEARCH
- CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
- (2017) Jiyeon Kim et al. NATURE
- Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass
- (2017) Jessica B. Spinelli et al. SCIENCE
- Glutamine metabolism regulates autophagy-dependent mTORC1 reactivation during amino acid starvation
- (2017) Hayden Weng Siong Tan et al. Nature Communications
- SIRT5 regulation of ammonia-induced autophagy and mitophagy
- (2015) Lucia Polletta et al. Autophagy
- ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
- (2015) M van Geldermalsen et al. ONCOGENE
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis
- (2011) Fei Liu et al. LIVER INTERNATIONAL
- Hepatocyte Nuclear Factor 4 Suppresses the Development of Hepatocellular Carcinoma
- (2010) B.-F. Ning et al. CANCER RESEARCH
- Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest
- (2009) T.L. Lam et al. CANCER LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now